Tremfya Market Forecast 2025-2034: Evaluating Growth Factors, Segments, and Emerging Trends

What combination of drivers is leading to accelerated growth in the tremfya market?
The increasing prevalence of autoimmune diseases is expected to propel the growth of the Tremfya market going forward. Autoimmune diseases refer to conditions in which the body's immune system mistakenly attacks its cells, tissues, or organs, perceiving them as foreign invaders. The increasing prevalence of autoimmune diseases is due to genetic predisposition, environmental triggers, lifestyle changes, increased awareness, and improved diagnostic capabilities. Tremfya is a monoclonal antibody targeting interleukin-23 (IL-23) that helps manage autoimmune diseases by modulating the immune system's overactive response, reducing inflammation, and alleviating symptoms in conditions such as psoriasis and psoriatic arthritis. For instance, in June 2024, according to a report published by the Australian Institute of Health and Welfare, an Australian-based governmental organization, in 2022, there were 10,000 hospitalizations for rheumatoid arthritis, marking a 25% increase from 8,000 in the previous year, with a hospitalization rate of 39 per 100,000 people. Therefore, the increasing prevalence of autoimmune diseases is driving the growth of the Tremfya market.

Get Your Tremfya Market Report Here:
https://www.thebusinessresearchcompany.com/report/tremfya-global-market-report

What is the projected compound annual growth rate (CAGR) of the tremfya market from 2025 to 2034, and what factors influence it?
The Tremfya market size has seen XX (HCAGR) in recent years. It will rise from $XX million in 2024 to $XX million in 2025, at a compound annual growth rate (CAGR) of XX%. The growth in the historic period is attributed to the increasing prevalence of psoriasis and psoriatic arthritis, a greater focus on targeted therapies, rising healthcare investments, a growing number of specialty clinics, and the increasing adoption of biologics in dermatology and rheumatology.

The Tremfya market size is projected to reach $XX million by 2029 at a CAGR of XX%. Growth drivers include increasing healthcare infrastructure, the rising adoption of point-of-care testing, growing investment in healthcare research, and a growing focus on precision medicine. Trends in the forecast period include advancements in treatment modalities, personalized medicine approaches, technological integration in patient monitoring, the rise of AI in healthcare, and improvements in injection devices.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20343&type=smp

How are the latest trends influencing the growth of the tremfya market?
A significant development in the Tremfya market is obtaining official approvals to increase its therapeutic indications like for moderate-to-severe Crohn's disease. This step enhances its potential patient pool and market scope. Regulatory approvals are endorsements given by organizations like the FDA or EMA, permitting the marketing of a drug for particular uses post-proving its safety, effectiveness, and quality. As an illustration, in September 2024, Johnson & Johnson, a pharmaceutical company based in the US, got FDA's nod for Tremfya (guselkumab) to treat adults with moderately to severely active ulcerative colitis, making it the first-ever dual-acting interleukin-23 inhibitor approved for such a condition. This approval owes its credit to the positive findings from the Phase 2b/3 QUASAR study, which revealed that almost half of the patients accomplished clinical remission post 44 weeks of therapy. Tremfya takes aim at interleukin-23, which aids in normalizing the inflammation response in the colon.

What are the major segments of the tremfya market and their role in driving growth?
The tremfya market covered in this report is segmented -

1) By Indication: Moderate-To-Severe Plaque Psoriasis; Active PsA
2) By Formulation: Subcutaneous Injection; Intravenous Infusion
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies
4) By End User: Adult Patients; Geriatric Patients

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20343

Which regions are key players in the growth of the tremfya market?
North America was the largest region in the tremfy market in 2024. The regions covered in the tremfya market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the tremfya market?
Major companies operating in the tremfya market are Johnson & Johnson

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20343&type=smp

What Is Covered In The Tremfya Global Market Report?

•Market Size Forecast: Examine the tremfya market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the tremfya market for a structured understanding.
•Key Players Overview: Analyze major players in the tremfya market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the tremfya market.
•Segment Contributions: Evaluate how different segments drive overall growth in the tremfya market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the tremfya market.
•Industry Challenges: Identify potential risks and obstacles affecting the tremfya market.
•Competitive Landscape: Review strategic developments in the tremfya market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.